-
Posted by
Two Blokes May 28 -
Filed in
Stock
-
3 views
Spero Therapeutics and partner GSK said on Wednesday that an experimental drug for complicated urinary tract infections met the main goal of a late-stage trial and the companies will be stopping the trial early for efficacy.
